09:00 - 12:20
主持人 Moderator
- 李云, 赛麦德咨询公司亚太区商务拓展负责人
- LI Yun, Asia Head of BD Deals of SAI MedPartners
09:00 - 09:20
- 主题报告
- Keynote Speech
- 把握市值管理机遇 提升医疗健康企业投资价值
- Leveraging Market Value Management to Enhance the Investment Value of Healthcare Organizations
- 迟永胜, 清华大学全球证券市场研究院秘书长
- CHI Yongsheng, Secretary-General of the Institute for Global Securities Market, Tsinghua University
09:20 - 09:40
- 项目1
- Project 1
- 肿瘤创新药从治疗到预防
- From Treatment to Prevention: The Next Generation of Innovative Cancer Drugs and Vaccines
- 夏芳, 思路迪（北京）医药科技有限公司董事会秘书&副总裁
- XIA Fang, Board Secretary & Vice Pricedent, 3D Medicines (Beijing) Co., Ltd.
09:40 - 10:00
- 项目2
- Project 2
- 全球商业化布局&新一代创新平台
- Global Commercial Portfolio & Next-Generation Innovative Platform
- 吴嘉俊, 和黄医药投资者关系和资本战略负责人及副总裁
- David Ng, Vice President & Head of Investor Relations and Capital Strategy, HUTCHMED
10:00 - 10:20
- 项目3
- Project 3
- 亚盛医药全球管线及业务布局
- Ascentage Pharma - Innovative Pipeline and Global Market Opportunities
- 黄智, 亚盛医药全球企业发展&财务高级副总裁
- Eric HUANG, SVP of Global Corporate Development & Finance, Ascentage Pharma Group International
10:20 - 10:40
- 项目4
- Project 4
- 依托小核酸技术构建差异化新药管线，探索慢病治疗新机遇
- Frontier Biotechnologies Inc. : Advancing siRNA-Based Drug Pipeline for Chronic Disease Innovation
- 谢东, 前沿生物药业（南京）股份有限公司董事长、总经理、首席科学家
- XIE Dong, Chairman & CEO & CSO, Frontier Biotechnologies Inc.（Nanjing）
10:40 - 11:00
- 项目5
- Project 5
- 聚焦肺癌靶向治疗，拓展肿瘤领域创新药开发
- Focus on Targeted Therapy for Lung Cancer, Expand the R&D of Innovative Drugs in the Field of Oncology
- 丁师哲, 贝达药业股份有限公司董事长助理
- Kevin DING, Chairman Assistant, Betta Pharmaceuticals Co., Ltd.
11:00 - 11:20
- 项目6
- Project 6
- 药捷安康创新药管线全球进展概览
- Overview of TransThera Global Innovative Pipeline
- 冯洁, 药捷安康（南京）科技股份有限公司董事会秘书
- FENG Jie, Secretary of the Board, TransThera Sciences (Nanjing), Inc.
11:20 - 11:40
- 项目7
- Project 7
- 以患者为中心的甘李药业代谢领域创新药管线布局
- Patient-Oriented Portfolio of Gan & Lee's Next-Generation GLP-1 RAs and Insulin
- 孙程, 甘李药业股份有限公司副总裁、CFO
- SUN Cheng, Vice President & CFO, Gan & Lee Pharmaceuticals, Co., Ltd.
11:40 - 12:00
- 项目8
- Project 8
- 诺诚健华医药有限公司项目进展
- InnoCare Pharma Limited– Pipeline and Project Updates
- 袁蓓, 诺诚健华医药有限公司投资者关系总监
- Bonnie YUAN, IRD, InnoCare Pharma Limited
12:00 - 12:20
- 项目9
- Project 9
- 艾德生物-伴随诊断赋能肿瘤新药中外同步开发
- AmoyDx Companion Diagnostics Harmonize China–Global Oncology Trials
- 薛雅馨, 厦门艾德生物医药科技股份有限公司助理总监
- Anita XUE, Associate Director, Amoy Diagnostics Co., Ltd.
会议咨询